Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: IL-36 s in the colorectal cancer: is interleukin 36 good or bad for the development of colorectal cancer?

Fig. 4

Survival curve analysis for sub-groups of CRC patients when defined by clinical presentation at surgery, comparing high and low expression levels of IL-36 s: by IL-36α production in patients with an invasion depth of T4 (a), lymph node metastasis (c), TNM III-IV (e), or right-sided colon CRC (g); or by IL-36γ production in patients with an invasion depth of T1–3 (b), no lymph node metastasis (d), TNM I-II (f), or left-sided colon CRC (h), using the Kaplan-Meier method and the log-rank test. X-axis represents days elapsed

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us